Company Filing History:
1 out of 5,463 
1 out of 6 Years Active: 2019
Title: The Innovative Contributions of Qingguo Zhao
Introduction
Qingguo Zhao is a notable inventor based in Temple, Texas, recognized for his significant contributions to the field of stem cell research. His work focuses on the development of mesenchymal stem cells derived from induced pluripotent stem cells, which has implications for therapeutic applications.
Latest Patents
Zhao holds a patent for a method of producing mesenchymal stem cells from induced pluripotent stem cells. This innovative method involves culturing induced pluripotent stem cells in the presence of a TGF-β inhibitor and in an atmosphere containing approximately 7 to 8 vol. % CO2 for a duration of 20 to 35 days. The cells are then transferred to a hydrophilic culture dish and cultured in a medium with a TGF-β inhibitor to produce stable mesenchymal stem cells. These cells are less likely to form tumors, cancers, or teratomas, making them a promising option for therapeutic use. Additionally, the induced pluripotent stem cells can be genetically engineered to express therapeutic agents, enhancing their potential for medical applications.
Career Highlights
Throughout his career, Qingguo Zhao has worked with esteemed institutions, including The Texas A&M University System and Temple Therapeutics, Inc. His research has contributed to advancements in regenerative medicine and cellular therapies.
Collaborations
Zhao has collaborated with notable colleagues such as Darwin J. Prockop and Fei Liu, further enhancing the impact of his research in the scientific community.
Conclusion
Qingguo Zhao's innovative work in stem cell research exemplifies the potential of induced pluripotent stem cells in medical applications. His contributions continue to pave the way for advancements in regenerative medicine and therapeutic solutions.